Chile · Delayed Price · Currency is CLP SNSE:PLANVITAL Statistics
Total Valuation
SNSE:PLANVITAL has a market cap or net worth of CLP 635.37 billion. The enterprise value is 565.38 billion.
| Market Cap | 635.37B |
| Enterprise Value | 565.38B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | Dec 5, 2025 |
Share Statistics
SNSE:PLANVITAL has 2.04 billion shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 2.04B |
| Shares Outstanding | 2.04B |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | -0.45% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 23.78M |
Valuation Ratios
The trailing PE ratio is 9.89.
| PE Ratio | 9.89 |
| Forward PE | n/a |
| PS Ratio | 4.39 |
| PB Ratio | 3.86 |
| P/TBV Ratio | 4.07 |
| P/FCF Ratio | 11.81 |
| P/OCF Ratio | 11.70 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.58, with an EV/FCF ratio of 10.51.
| EV / Earnings | 8.80 |
| EV / Sales | 3.91 |
| EV / EBITDA | 6.58 |
| EV / EBIT | 6.71 |
| EV / FCF | 10.51 |
Financial Position
The company has a current ratio of 1.55, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.55 |
| Quick Ratio | 1.52 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.07 |
| Interest Coverage | 344.96 |
Financial Efficiency
Return on equity (ROE) is 44.03% and return on invested capital (ROIC) is 34.66%.
| Return on Equity (ROE) | 44.03% |
| Return on Assets (ROA) | 25.52% |
| Return on Invested Capital (ROIC) | 34.66% |
| Return on Capital Employed (ROCE) | 46.27% |
| Revenue Per Employee | 179.60M |
| Profits Per Employee | 79.79M |
| Employee Count | 862 |
| Asset Turnover | 0.71 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SNSE:PLANVITAL has paid 21.35 billion in taxes.
| Income Tax | 21.35B |
| Effective Tax Rate | 24.94% |
Stock Price Statistics
The stock price has increased by +90.71% in the last 52 weeks. The beta is 0.05, so SNSE:PLANVITAL's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | +90.71% |
| 50-Day Moving Average | 259.65 |
| 200-Day Moving Average | 219.07 |
| Relative Strength Index (RSI) | 89.63 |
| Average Volume (20 Days) | 75,700 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SNSE:PLANVITAL had revenue of CLP 144.57 billion and earned 64.23 billion in profits. Earnings per share was 31.54.
| Revenue | 144.57B |
| Gross Profit | 144.57B |
| Operating Income | 83.02B |
| Pretax Income | 85.58B |
| Net Income | 64.23B |
| EBITDA | 84.08B |
| EBIT | 83.02B |
| Earnings Per Share (EPS) | 31.54 |
Balance Sheet
The company has 73.88 billion in cash and 3.89 billion in debt, giving a net cash position of 69.99 billion or 34.36 per share.
| Cash & Cash Equivalents | 73.88B |
| Total Debt | 3.89B |
| Net Cash | 69.99B |
| Net Cash Per Share | 34.36 |
| Equity (Book Value) | 164.79B |
| Book Value Per Share | 80.91 |
| Working Capital | 28.54B |
Cash Flow
In the last 12 months, operating cash flow was 54.32 billion and capital expenditures -541.40 million, giving a free cash flow of 53.78 billion.
| Operating Cash Flow | 54.32B |
| Capital Expenditures | -541.40M |
| Free Cash Flow | 53.78B |
| FCF Per Share | 26.40 |
Margins
Gross margin is 100.00%, with operating and profit margins of 57.42% and 44.43%.
| Gross Margin | 100.00% |
| Operating Margin | 57.42% |
| Pretax Margin | 59.20% |
| Profit Margin | 44.43% |
| EBITDA Margin | 58.16% |
| EBIT Margin | 57.42% |
| FCF Margin | 37.20% |
Dividends & Yields
This stock pays an annual dividend of 13.22, which amounts to a dividend yield of 4.24%.
| Dividend Per Share | 13.22 |
| Dividend Yield | 4.24% |
| Dividend Growth (YoY) | -27.01% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 41.86% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 4.24% |
| Earnings Yield | 10.11% |
| FCF Yield | 8.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SNSE:PLANVITAL has an Altman Z-Score of 6.21 and a Piotroski F-Score of 4.
| Altman Z-Score | 6.21 |
| Piotroski F-Score | 4 |